Project Details
Description
Primary objective:
To estimate the prevalence of patients who are at high-risk for Fabry Disease (FD) in the Cleveland Clinic, Abu Dhabi (CCAD) United Arab Emirates (EMR) database from May 2016 to May 2022, according to the predictive algorithm (i.e., feasibility assessment eligibility criteria)
Secondary objectives:
- To estimate the prevalence of FD among patients at high-risk for FD (i.e., among enrolled patients)
- To characterize the patient profile, overall and in Cohorts 1 and 2
- To describe the most common characteristics among positive FD patients and negative FD patients.
To estimate the prevalence of patients who are at high-risk for Fabry Disease (FD) in the Cleveland Clinic, Abu Dhabi (CCAD) United Arab Emirates (EMR) database from May 2016 to May 2022, according to the predictive algorithm (i.e., feasibility assessment eligibility criteria)
Secondary objectives:
- To estimate the prevalence of FD among patients at high-risk for FD (i.e., among enrolled patients)
- To characterize the patient profile, overall and in Cohorts 1 and 2
- To describe the most common characteristics among positive FD patients and negative FD patients.
| Status | Finished |
|---|---|
| Effective start/end date | 28/07/23 → 14/12/23 |
Collaborative partners
- Sanofi (lead)
- Cleveland Clinic Abu Dhabi
Keywords
- Sphingolipidoses
- Lysosomal Storage Diseases, Nervous System
- Brain Diseases, Metabolic, Inborn
- Brain Diseases, Metabolic
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Cerebral Small Vessel Diseases
- Cerebrovascular Disorders
- Vascular Diseases
- Cardiovascular Diseases
- Genetic Diseases, X-Linked
- Genetic Diseases, Inborn
- Metabolism, Inborn Errors
- Lipidoses
- Lipid Metabolism, Inborn Errors
- Lysosomal Storage Diseases
- Metabolic Diseases
- Lipid Metabolism Disorders
- Fabry Disease
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.